Spine Doctor in Bangalore Redefines Spine Care with an Enhanced Digital Platform
NV
3 min read
29

Spine Doctor in Bangalore Redefines Spine Care with an Enhanced Digital Platform

December 14, 2024
0

Reading Time: 2 minutes Dr. Umesh Srinkantha, the most famous spine doctor in Bangalore, and the founder of Spine360, has come up with two huge achievements in spine care. The first one is the release of a new digital platform which unlike the other ones was specifically created to

Continue Reading
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
BWI
4 min read
28

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

December 14, 2024
0

Reading Time: 3 minutes Mont-Saint-Guibert, Belgium & TOKYO, Japan:   BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing, today announced a process development and manufacturing

Continue Reading
Temporal Delivers Temporal Cloud Through Google Cloud Marketplace
BWI
3 min read
30

Temporal Delivers Temporal Cloud Through Google Cloud Marketplace

December 14, 2024
0

Reading Time: 2 minutes Seattle, United States:   Temporal Technologies today announced the availability of Temporal Cloud on Google Cloud Marketplace, offering developers in the Google Cloud ecosystem the most streamlined path to using Temporal Cloud.   Temporal is an open-source, code-first workflow orchestration

Continue Reading
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
BWI
13 min read
27

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

December 14, 2024
0

Reading Time: 9 minutes Zug, Switzerland:   Ad hoc announcement pursuant to Art. 53 LR   Approximately 7% of people in the United States (U.S.) have atopic dermatitis – a common, chronic, and flaring inflammatory skin disease, characterized by persistent itch and recurrent skin lesions1-4

Continue Reading
Experian’s 2024 Global Identity & Fraud Report Spotlights Huge Growth in Highly Personalized GenAI-Driven Fraud Attacks
BWI
3 min read
26

Experian’s 2024 Global Identity & Fraud Report Spotlights Huge Growth in Highly Personalized GenAI-Driven Fraud Attacks

December 14, 2024
0

Reading Time: 3 minutes Dublin, Ireland & Costa Mesa, Calif., United States:   Today, Experian announced its 2024 Global Identity & Fraud Report that provides a comprehensive view of the consumer and business response to the latest fraud patterns and fraud‑mitigation strategies in the worldwide financial

Continue Reading
CSP
1 min read
25

#24-123 Lohilo Foods AB approved for listing at NGM

December 14, 2024
0

Reading Time: < 1 minute Nordic Growth Market NGM AB (“NGM“) has, as previously announced, decided to list the shares in Lohilo Foods AB at NGM. The first day of trading has been set to December 20, 2024 The shares in Lohilo Foods AB have

Continue Reading
CSP
1 min read
30

Change in the amount of Finnair Plc treasury shares

December 14, 2024
0

Reading Time: < 1 minute Finnair Plc   Stock Exchange Release   13 December 2024 at 4:30 p.m. EET Finnair Plc has today, based on the decision made by the Board of Directors of the company, transferred without consideration 43,798 own shares held by the company, as

Continue Reading
CSP
3 min read
18

Pihlajalinna establishes a new long-term share-based incentive plan for key employees

December 13, 2024
0

Reading Time: 2 minutes Pihlajalinna Plc          Stock Exchange Release          13 December 2024 at 5:45 p.m. Pihlajalinna establishes a new long-term share-based incentive plan for key employees The Board of Directors of Pihlajalinna Plc has resolved to establish a new long-term share-based incentive plan for key

Continue Reading
CSP
1 min read
19

#24-430 Listing of Derivatives at NGM

December 13, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
1 min read
24

Nordea Bank Abp: Repurchase of own shares on 13.12.2024

December 13, 2024
0

Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares13.12.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 13.12.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average

Continue Reading